Grant supports gene-editing research for rare metabolic diseases

A $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at the University of Pennsylvania (Penn) and Children’s Hospital of Philadelphia (CHOP).

The AI-Powered Lab Assistant with Scientific Awareness

Enhancing healthcare research, Sapio Sciences’ solutions unify lab data management, leveraging AI to improve efficiency and accelerate drug development cycles.

October 25, 2024

PharmaDrug Inc. Completes Debt Restructuring | Psychedelic Invest

PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company“), is pleased to announce that it has closed the previously announced debt restructuring (see

November 16, 2023

Evotec and Pfizer announce drug discovery collaboration

The companies will focus on research for metabolic and infectious diseases. Credit: Orawan Pattarawimonchai/Shutterstock. Evotec and Pfizer have entered a multi-year partnership that will focus

July 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.